Max International has developed and distributed proprietary and patent-protected nutritional that Strengthen Immunity.
Max is now emphasizing on the importance of Glutathione stating that its the most important endogenous antioxidant for cellular defense against oxidative stress and effectively provides a major defense system against illness and aging.
Oxidative stress is a metabolic condition where excess free radicals are being produced.
Medics say chronic oxidative stress has been associated with many diseases and disorders, including cardiovascular diseases, neurodegenerative disorders, cataract formation among others.
“Max’s singular proposition is to help people get the most out of their lives, from both a health and wealth perspective. Max is an opportunity company for its distributors as it incorporates both a direct selling and MLM, multi-level marketing model for its glutathione-supporting nutraceuticals. (Wellness, weight-loss, and fitness performance),” Max International Chief Executive Officer Joseph Voyticky said.
Voyticky commented that a person with a weakened immunity has a higher risk of experiencing frequent infections and severe symptoms.
According to medics, a person with a weakened immune system is more prone to pneumonia and other conditions.
The bacteria and viruses, including the virus that causes the COVID-19 infection, can have a devastating effect on a person with a compromised immune system.
Max’s nutraceutical products focus on helping the cells of the body to produce glutathione or support glutathione’s functions.
Through several products by Max International, Voyticky added that a person can strengthen their immunity and subsequently improve their wellbeing and that the body has a way to fight the free radicals released from the stress.
“Glutathione production naturally declines as we age and bodily stores are depleted when we are stressed, when we lack sleep, or have suffered prolonged illnesses, Glutathione’s role in the human body is so extensive that over 75 diseases are associated with low glutathione levels,” said Joseph Voyticky.
Max’s patented molecule, RiboCeine represent the holy grail of nutraceutical technology with respect to glutathione.
These products enhance endogenous production of glutathione and deliver exogenous glutathione to the cell.
There are currently 44 peer-reviewed research studies demonstrating the effectiveness of Max’s flagship patented molecule RiboCeine Cell death in the liver may be exacerbated by a deficiency in antioxidants, including glutathione.
The company is the leading provider of effective glutathione enhancing nutritional supplements and makes it the leading provider of effective and cost-efficient glutathione boosting supplements.
Its technology position and compelling business opportunity turn Max into a leading contender in the direct selling industry.
